When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar Bio's CLR 131 Fast Track'd for lymphatic system cancer
Cellectar Biosciences Inc.
The FDA grants Fast Track status to Cellectar Biosciences (NASDAQ:CLRB) CLR 131 application for patients with lymphoplasmacytic lymphoma (LPL)/Waldenstrom’s macroglobulinemia (WM) in patients who have received at least two prior lines of therapy.
More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move,